Prostate cancer is one of the most common cancers among men in the U.S. About 1 in 8 men will be diagnosed with prostate cancer in their lifetime, according to the American Cancer Society. But experts ...

FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.

Fear of discomfort and unnecessary treatment often deters patients from prostate cancer screening, despite the benefits of early detection. Prostate cancer can be asymptomatic, making early detection ...

When it comes to detecting cancer, you want the fastest detection possible in order to treat it accurately and in a timely ...

"This technology gives us a powerful tool to detect prostate cancer earlier and more precisely,” said Dr. James Howard.

In a biopsy, a small sample of tissue is taken from your body. A pathologist analyzes the sample to check for cancer cells. The main method for diagnosing prostate cancer is a core needle biopsy. It’s ...

RIB MOUNTAIN, Wis. (WSAW) - About one in eight men will be diagnosed with prostate cancer during their lifetime, according to the American Cancer Society. The best way to be among the millions of ...

BALTIMORE, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Today, the American Urological Association (AUA), in partnership with the Society of Urologic Oncology (SUO), released the 2026 amendment to the Early ...

Data from Vista Health, a leading UK provider of private diagnostic services, has revealed the worrying knowledge gap when it comes to the prostate, as 26 percent of men do not know what their ...